Spironolactone is one of the most common medications used to suppress endogenous testosterone in trans female patients. Retrieved 8 December Peak levels for parenteral testosterone measured 24—48 hrs after injection. Estimation of prevalence of transgenderism has historically been challenging. Routine laboratory monitoring of patients on cross-sex hormone therapy can be challenging because results are often reported using gender-specific reference intervals, which are not all appropriate for transgender patients. World Professional Association for Transgender Health.
Many of the studies that currently exist have small patient numbers as well as short or medium-term follow-up, and very few of the patients studied are over the age of
Eur J Endocrinol ; Biol Psychiatry ; Leuprorelin, along with triptorelin and goserelinare often used to delay puberty in transgender youth until they are old enough to begin hormone replacement therapy. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Sex steroid antagonists via disinhibition of the HPG axis: Many transgender individuals seek cross-sex hormone therapy for treatment of gender dysphoria.